Responses
RCEM 2015 Abstracts
TOP SCORING NON TRAINEES
009
INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONS
Compose a Response to This Article
Other responses
No responses have been published for this article.